TNFRSF19
Tumor necrosis factor receptor superfamily member 19
Also known as: TAJ, TAJ-alpha, TNR19_HUMAN, TRADE, TROY
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NS68
- Gene
- TNFRSF19
- Ensembl
- ENSG00000127863
- Chromosome
- 13
- Canonical length
- 423 aa
- Protein class
- Plasma proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus
OverviewNCBI Gene
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is highly expressed during embryonic development. It has been shown to interact with TRAF family members, and to activate JNK signaling pathway when overexpressed in cells. This receptor is capable of inducing apoptosis by a caspase-independent mechanism, and it is thought to play an essential role in embryonic development. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
423 residues, UniProt reviewed canonical sequence.
>Q9NS68|TNFRSF19
1 MALKVLLEQE KTFFTLLVLL GYLSCKVTCE SGDCRQQEFR DRSGNCVPCN QCGPGMELSK
61 ECGFGYGEDA QCVTCRLHRF KEDWGFQKCK PCLDCAVVNR FQKANCSATS DAICGDCLPG
121 FYRKTKLVGF QDMECVPCGD PPPPYEPHCA SKVNLVKIAS TASSPRDTAL AAVICSALAT
181 VLLALLILCV IYCKRQFMEK KPSWSLRSQD IQYNGSELSC FDRPQLHEYA HRACCQCRRD
241 SVQTCGPVRL LPSMCCEEAC SPNPATLGCG VHSAASLQAR NAGPAGEMVP TFFGSLTQSI
301 CGEFSDAWPL MQNPMGGDNI SFCDSYPELT GEDIHSLNPE LESSTSLDSN SSQDLVGGAV
361 PVQSHSENFT AATDLSRYNN TLVESASTQD ALTMRSQLDQ ESGAVIHPAT QTSLQVRQRL
421 GSLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TNFRSF19 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 102 nTPM
Expression across tissuesHPA
Tissue
- skin: 102 nTPM
- salivary gland: 52 nTPM
- fallopian tube: 29 nTPM
- prostate: 26 nTPM
- heart muscle: 21 nTPM
- lung: 16 nTPM
Single-cell type
- salivary acinar cells: 585 nCPM
- lacrimal acinar cells: 332 nCPM
- prostatic glandular cells: 253 nCPM
- respiratory ciliated cells: 237 nCPM
- pituicytes/fscs: 228 nCPM
- cardiomyocytes: 159 nCPM
Immune cell
- T-reg: 1.3 nTPM
- naive B-cell: 0.5 nTPM
- eosinophil: 0.2 nTPM
- memory B-cell: 0.2 nTPM
- plasmacytoid DC: 0.2 nTPM
- MAIT T-cell: 0.1 nTPM
Brain region
- choroid plexus: 8.6 nTPM
- medulla oblongata: 7.1 nTPM
- midbrain: 6.7 nTPM
- spinal cord: 6.4 nTPM
- thalamus: 5.4 nTPM
- hypothalamus: 5.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.72
- gnomAD pLI
- 0.03
- gnomAD missense Z
- 0.23
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- hair follicle development
- JNK cascade
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of JNK cascade
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- TNFR/NGFR cysteine-rich region
- Tumor necrosis factor receptor superfamily member 19/27/EDAR
- Tumour necrosis factor receptor 19
- Tumor necrosis factor receptor 19, N-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TNFRSF19 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TNFRSF19 as an antibody target. Whether an autoantibody or antibody against TNFRSF19 could matter depends on whether native TNFRSF19 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TNFRSF19 is annotated at the cell surface, where native TNFRSF19 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TNFRSF19 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...